LISATA THERAPEUTICS, INC. Deferred State and Local Income Tax Expense (Benefit)
LISATA THERAPEUTICS, INC. (LSTA) reported Deferred State and Local Income Tax Expense (Benefit) of -$962.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was -$962.00K.
- LISATA THERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was -$798.00K.
- LISATA THERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was -$2.33M.
- LISATA THERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was -$2.48M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$962.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | -$798.00K 10-K · filed 2026-03-12 | |
| 2023-12-31 | -$2.33M 10-K · filed 2025-02-27 | |
| 2022-12-31 | -$2.48M 10-K · filed 2024-02-29 | |
| 2021-12-31 | -$1.51M 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$10.87M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | $28.60K 10-K · filed 2017-03-17 |
| 2015-12-31 | -$2.55M 10-K · filed 2017-03-17 | |
| 2014-12-31 | -$263.20K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $303.20K 10-K · filed 2016-03-15 | |
| 2012-12-31 | -$175.50K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |